# Transdermal Versus Oral Oxybutynin in Pediatric OAB

> **NCT07081906** · NA · COMPLETED · sponsor: **Dr. Lutfi Kirdar Kartal Training and Research Hospital** · enrollment: 90 (actual)

## Conditions studied

- Overactive Bladder (OAB)
- Drug Delivery Systems
- Anticholinergic Side Effects
- Children and Adolescents, Boys and Girls

## Interventions

- **DRUG:** Oral Oxybutynin
- **DRUG:** transdermal oxybutinin

## Key facts

- **NCT ID:** NCT07081906
- **Lead sponsor:** Dr. Lutfi Kirdar Kartal Training and Research Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-15
- **Primary completion:** 2019-07-15
- **Final completion:** 2020-05-01
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2025-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07081906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07081906, "Transdermal Versus Oral Oxybutynin in Pediatric OAB". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07081906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*